The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Antibody-drug conjugates combinations in cancer treatment”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2024 |
Whi-An Kwon, Min-Kyung Lee. Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives, Cancers. 2024; 16: 4078. https://doi.org/10.3390/cancers16234078 |
|
2 |
2025 |
Matthew V. Holt, Yongchao Dou, Meggie N. Young, Alexander B. Saltzman, Meenakshi Anurag, Jonathan T. Lei, Antrix Jain, Mei Leng, Beom-Jun Kim, Lacey E. Dobrolecki, Stefanie F. Faucher, Sara Savage, Chenwei Wang, Zhiao Shi, Hugo Villanueva, Karoline Kremers, Kyle D. Drinnon, Patricia D. Castro, Michael M. Ittmann, Mehak Mehboob Khatani, Sung Han Kim, Matthew J. Ellis, Bing Zhang, Anna Malovannaya, Seth P. Lerner. Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer, Cell Reports Medicine. 2025; 102255102255. https://doi.org/10.1016/j.xcrm.2025.102255 |
|
3 |
2025 |
Revu V. L. Narayana, Romi Gupta. Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment, Oncogene. 2025; 44: 2343. https://doi.org/10.1038/s41388-025-03448-3 |